CRISPR/Cas-Based Biosensor As a New Age Detection Method for Pathogenic Bacteria.

Area of Science:

• Microbiology
• Molecular Biology
• Biotechnology

Background:

• Rapid and on-site pathogenic bacteria detection is crucial for public health, diagnostics, and food safety.
• Existing detection methods are often inconvenient and time-consuming, limiting field applicability.
• The CRISPR/Cas system, a bacterial adaptive immune mechanism, shows promise for advanced pathogen detection.

Purpose of the Study:

• To review CRISPR/Cas-based techniques for pathogenic bacteria detection.
• To highlight the potential of CRISPR/Cas systems in overcoming current detection limitations.
• To discuss applications in detecting specific bacteria relevant to public health.

Main Methods:

• Review of existing literature on CRISPR/Cas systems for pathogen detection.
• Analysis of CRISPR/Cas mechanisms (CRISPR array, Cas proteins) in bacterial immunity.
• Compilation of CRISPR/Cas applications for detecting various pathogenic bacteria.

Main Results:

• CRISPR/Cas systems offer high sensitivity and specificity for DNA/RNA targeting.
• While established for viral detection, CRISPR/Cas applications for bacteria are emerging.
• Specific CRISPR/Cas techniques have been developed for detecting L. monocytogenes, M. tuberculosis, MRSA, Salmonella, E. coli, P. aeruginosa, and A. baumannii.

Conclusions:

• CRISPR/Cas technology presents a significant advancement for sensitive and specific bacterial detection.
• Further development of CRISPR/Cas systems can enhance on-site and rapid detection capabilities.
• This technology holds potential to become a leading method in bacterial diagnostics and surveillance.